Results 241 to 250 of about 1,672,248 (364)

Downregulation of O‐GlcNAcylation enhances etoposide‐induced p53‐mediated apoptosis in HepG2 human liver cancer cells

FEBS Open Bio, EarlyView.
Etoposide, a topoisomerase II inhibitor, reduces O‐GlcNAcylation in HepG2 liver cancer cells. Further inhibition of O‐GlcNAc transferase by OSMI‐1 enhanced etoposide‐induced apoptosis, lowering the IC50 for viability and increasing the EC50 for cytotoxicity.
Jaehoon Lee, Gi‐Bang Koo, Jihye Park, Byung‐Cheol Han, Mijin Kwon, Seung‐Ho Lee   +5 more
wiley   +1 more source

Recent advances in the role of polysaccharides in liver diseases: a review. [PDF]

Front Pharmacol
Wang J, Wang H, Yang X, Wang K, Zhang Y.
europepmc   +1 more source

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Involvement of SIRT1-mediated aging in liver diseases. [PDF]

Front Cell Dev Biol
Zhang Y, Gong C, Tao L, Zhai J, Huang F, Zhang S.   +5 more
europepmc   +1 more source

Polycystic Disease of the Liver, Pancreas and Kidneys [PDF]

, 1939
Manville W. Norton
openalex   +1 more source

Cytokines and Liver Disease.

Japanese Journal of Medicine, 1991
openaire   +6 more sources

Liver diseases: epidemiology, causes, trends and predictions. [PDF]

Signal Transduct Target Ther
Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, Guo Y, Wang H, Dong E, Xiao J.   +9 more
europepmc   +1 more source

Diet and Disease of the Liver [PDF]

, 1949
L. E. Glynn
openalex   +1 more source

Understanding and Overcoming Immunotherapy Resistance in Skin Cancer: Mechanisms and Strategies

Aging and Cancer, EarlyView.
This narrative review explores the mechanisms driving immunotherapy resistance in skin cancer, including tumor microenvironment factors, genetic mutations, and immune evasion strategies. It highlights potential strategies to overcome resistance, offering insights for improving therapeutic outcomes and guiding future research in personalized ...
Shreya Singh Beniwal, Abhimanyu Chiraparambil Radhakrishnan, Ayanchetty Haripraba, Saif Syed, Gajawada Pragna, Ayush Dwivedi, Akash Rawat, Daniela Castro Calderón, Martin Cevallos‐Cueva   +8 more
wiley   +1 more source

Post-COVID-19 Pandemic Sequelae in Liver Diseases. [PDF]

Life (Basel)
Stasi C.
europepmc   +1 more source